Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.

Pinches M, Betts C, Bickerton S, Burdett L, Thomas H, Derbyshire N, Jones HB, Moores M.

Toxicol Pathol. 2012 Apr;40(3):522-33. doi: 10.1177/0192623311432438.

PMID:
22491933
2.

Evaluation of novel urinary renal biomarkers: biological variation and reference change values.

Pinches MD, Betts CJ, Bickerton SJ, Beattie L, Burdett LD, Thomas HT, Derbyshire NA, Moores M, Price SA.

Toxicol Pathol. 2012 Apr;40(3):541-9. doi: 10.1177/0192623311432436. Epub 2012 Mar 6.

PMID:
22395790
3.

Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.

Harpur E, Ennulat D, Hoffman D, Betton G, Gautier JC, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M, Shaw M, Lock E, Pettit S; HESI Committee on Biomarkers of Nephrotoxicity.

Toxicol Sci. 2011 Aug;122(2):235-52. doi: 10.1093/toxsci/kfr112. Epub 2011 May 18.

PMID:
21593213
4.

Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats.

Tonomura Y, Tsuchiya N, Torii M, Uehara T.

Toxicology. 2010 Jun 29;273(1-3):53-9. doi: 10.1016/j.tox.2010.04.015. Epub 2010 May 10.

PMID:
20438795
5.

Evaluation of novel urinary renal biomarkers with a cisplatin model of kidney injury: effects of collection period.

Pinches MD, Betts CJ, Bickerton SJ, Beattie L, Burdett LD, Thomas HT, Derbyshire NA, Moores M.

Toxicol Pathol. 2012 Apr;40(3):534-40. doi: 10.1177/0192623311432437. Epub 2012 Jan 13.

PMID:
22246543
6.

Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.

Vlasakova K, Erdos Z, Troth SP, McNulty K, Chapeau-Campredon V, Mokrzycki N, Muniappa N, Gu YZ, Holder D, Bailey WJ, Sistare FD, Glaab WE.

Toxicol Sci. 2014 Mar;138(1):3-20. doi: 10.1093/toxsci/kft330. Epub 2013 Dec 21.

PMID:
24361871
7.

Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.

Rouse RL, Stewart SR, Thompson KL, Zhang J.

Toxicol Pathol. 2013;41(4):662-80. doi: 10.1177/0192623312464122. Epub 2012 Oct 19.

PMID:
23085980
8.

Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.

Hosohata K, Ando H, Fujimura A.

J Pharmacol Exp Ther. 2012 Jun;341(3):656-62. doi: 10.1124/jpet.112.192807. Epub 2012 Mar 7.

9.

Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats.

Togashi Y, Sakaguchi Y, Miyamoto M, Miyamoto Y.

Exp Toxicol Pathol. 2012 Nov;64(7-8):797-805. doi: 10.1016/j.etp.2011.01.018. Epub 2011 Mar 5.

PMID:
21377848
10.

Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.

Betton GR, Ennulat D, Hoffman D, Gautier JC, Harpur E, Pettit S.

Toxicol Pathol. 2012 Jun;40(4):682-94. doi: 10.1177/0192623311436174. Epub 2012 Feb 1.

PMID:
22301952
11.

Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.

Wadey RM, Pinches MG, Jones HB, Riccardi D, Price SA.

Toxicol Pathol. 2014;42(3):591-602. doi: 10.1177/0192623313492044. Epub 2013 Jul 3.

PMID:
23823703
12.

Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats.

Tonomura Y, Uehara T, Yamamoto E, Torii M, Matsubara M.

Toxicology. 2011 Dec 18;290(2-3):241-8. doi: 10.1016/j.tox.2011.10.001. Epub 2011 Oct 8.

PMID:
22005293
13.

Renal biomarkers predict nephrotoxicity after paraquat.

Wunnapuk K, Liu X, Peake P, Gobe G, Endre Z, Grice JE, Roberts MS, Buckley NA.

Toxicol Lett. 2013 Oct 9;222(3):280-8. doi: 10.1016/j.toxlet.2013.08.003. Epub 2013 Aug 14.

PMID:
23954200
14.

Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.

Gautier JC, Riefke B, Walter J, Kurth P, Mylecraine L, Guilpin V, Barlow N, Gury T, Hoffman D, Ennulat D, Schuster K, Harpur E, Pettit S.

Toxicol Pathol. 2010 Oct;38(6):943-56. doi: 10.1177/0192623310379139. Epub 2010 Aug 17.

PMID:
20716785
15.

Kidney biomarkers in MCPA-induced acute kidney injury in rats: reduced clearance enhances early biomarker performance.

Wunnapuk K, Liu X, Gobe GC, Endre ZH, Peake PW, Grice JE, Roberts MS, Buckley NA.

Toxicol Lett. 2014 Mar 21;225(3):467-78. doi: 10.1016/j.toxlet.2014.01.018. Epub 2014 Jan 27.

PMID:
24480514
17.

Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.

Hoffmann D, Fuchs TC, Henzler T, Matheis KA, Herget T, Dekant W, Hewitt P, Mally A.

Toxicology. 2010 Nov 9;277(1-3):49-58. doi: 10.1016/j.tox.2010.08.013. Epub 2010 Sep 9.

PMID:
20816719
18.

Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials.

Fuchs TC, Frick K, Emde B, Czasch S, von Landenberg F, Hewitt P.

Toxicol Pathol. 2012 Oct;40(7):1031-48. Epub 2012 May 11.

PMID:
22581810
19.

Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.

Waring WS, Moonie A.

Clin Toxicol (Phila). 2011 Oct;49(8):720-8. doi: 10.3109/15563650.2011.615319. Review.

PMID:
21970770
20.

Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.

Bulacio RP, Torres AM.

Arch Toxicol. 2013 Nov;87(11):1953-1962. doi: 10.1007/s00204-013-1062-0. Epub 2013 May 7.

PMID:
23649842

Supplemental Content

Support Center